aluminum hydroxide, magnesium hydroxide, drug combination has been researched along with omeprazole in 9 studies
| Studies (aluminum hydroxide, magnesium hydroxide, drug combination) | Trials (aluminum hydroxide, magnesium hydroxide, drug combination) | Recent Studies (post-2010) (aluminum hydroxide, magnesium hydroxide, drug combination) | Studies (omeprazole) | Trials (omeprazole) | Recent Studies (post-2010) (omeprazole) |
|---|---|---|---|---|---|
| 253 | 100 | 17 | 9,085 | 2,737 | 1,487 |
| Protein | Taxonomy | aluminum hydroxide, magnesium hydroxide, drug combination (IC50) | omeprazole (IC50) |
|---|---|---|---|
| Mcl-1 | Homo sapiens (human) | 3.1448 | |
| cGMP-specific 3',5'-cyclic phosphodiesterase | Homo sapiens (human) | 0.28 | |
| Potassium-transporting ATPase alpha chain 1 | Homo sapiens (human) | 1.45 | |
| Cytochrome P450 2C19 | Homo sapiens (human) | 2.315 | |
| Potassium-transporting ATPase subunit beta | Homo sapiens (human) | 1.45 | |
| WD repeat-containing protein 5 | Homo sapiens (human) | 1.7 | |
| Glutathione S-transferase omega-1 | Homo sapiens (human) | 4.6 | |
| Histone-lysine N-methyltransferase 2A | Homo sapiens (human) | 1.7 | |
| Muscarinic acetylcholine receptor | Cavia porcellus (domestic guinea pig) | 3.8 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 7 (77.78) | 18.2507 |
| 2000's | 1 (11.11) | 29.6817 |
| 2010's | 1 (11.11) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brzozowski, T; Garlicki, J; Konturek, SJ; Majka, J; Nauert, C; Stachura, J | 1 |
| Benoit, M; Cournot, A; Delhotal-Landes, B; Dellatolas, F; Flouvat, B; Vermerie, N | 1 |
| Bridger, S; Johnston, DA; Marks, IN; Tigler-Wybrandi, NA; Young, GO; Zak, J | 1 |
| Folwaczny, C | 1 |
| Meiser, BM; Muschiol, F; Nollert, G; Pfeiffer, M; Reichart, B; Reichenspurner, H; Uberfuhr, P; Vetter, HO; Wagner, F | 1 |
| Dogolo, LC; Friedman, HL; Teng, R; Vincent, J; Willavize, SA | 1 |
| Azuumi, Y; Iwao, K; Saitoh, H; Takada, M; Takeda, K | 1 |
| Langholff, W; Milosavljev, S; Rordorf, C; Scott, G; Shenouda, M; Vinluan Reynolds, C | 1 |
| Boulton, DW; Ren, S | 1 |
7 trial(s) available for aluminum hydroxide, magnesium hydroxide, drug combination and omeprazole
| Article | Year |
|---|---|
The effect of food and antacids on lansoprazole absorption and disposition.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aluminum Hydroxide; Antacids; Anti-Ulcer Agents; Biological Availability; Drug Combinations; Female; Food; Half-Life; Humans; Lansoprazole; Magnesium Hydroxide; Male; Omeprazole; Tablets, Enteric-Coated | 1991 |
Acid secretory responses and parietal cell sensitivity following duodenal ulcer healing with omeprazole, sucralfate, and Maalox.
Topics: Adult; Aged; Aluminum Hydroxide; Antacids; Drug Combinations; Duodenal Ulcer; Endoscopy, Gastrointestinal; Fasting; Female; Gastric Acid; Gastric Acidity Determination; Gastrins; Humans; Magnesium Hydroxide; Male; Middle Aged; Omeprazole; Parietal Cells, Gastric; Pentagastrin; Recurrence; Sucralfate; Wound Healing | 1991 |
[Antibacterial treatment of gastric ulcers associated with Helicobacter pylori without acid suppression].
Topics: Aluminum Hydroxide; Antacids; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Drug Combinations; Drug Therapy, Combination; Gastric Acidity Determination; Helicobacter Infections; Helicobacter pylori; Humans; Magnesium Hydroxide; Metronidazole; Omeprazole; Simethicone; Stomach Ulcer; Tetracycline | 1995 |
Changes of resorption and metabolism of cyclosporine after heart transplantation by the influence of gastrointestinal agents.
Topics: Administration, Oral; Aluminum Hydroxide; Animals; Antacids; Anti-Ulcer Agents; Antilymphocyte Serum; Azathioprine; Cimetidine; Cyclosporine; Drug Combinations; Famotidine; Female; Heart Transplantation; Humans; Intestinal Absorption; Magnesium Hydroxide; Male; Middle Aged; Omeprazole; Pirenzepine; Prednisone; Rats; Rats, Inbred BN | 1994 |
Effect of Maalox and omeprazole on the bioavailability of trovafloxacin.
Topics: Adult; Aluminum Hydroxide; Antacids; Anti-Infective Agents; Area Under Curve; Biological Availability; Drug Combinations; Fluoroquinolones; Humans; Magnesium Hydroxide; Male; Naphthyridines; Omeprazole | 1997 |
Lack of effect of omeprazole or of an aluminium hydroxide/magnesium hydroxide antacid on the pharmacokinetics of lumiracoxib.
Topics: Adolescent; Adult; Aluminum Hydroxide; Antacids; Area Under Curve; Cross-Over Studies; Cyclooxygenase 2; Diclofenac; Drug Combinations; Enzyme Inhibitors; Female; Humans; Isoenzymes; Magnesium Hydroxide; Male; Membrane Proteins; Middle Aged; Omeprazole; Organic Chemicals; Prostaglandin-Endoperoxide Synthases; Proton Pump Inhibitors | 2004 |
Pharmacokinetic Interaction Study Between Saxagliptin and Omeprazole, Famotidine, or Magnesium and Aluminum Hydroxides Plus Simethicone in Healthy Subjects: An Open-Label Randomized Crossover Study.
Topics: Adamantane; Adult; Aluminum Hydroxide; Area Under Curve; Cross-Over Studies; Dipeptides; Drug Combinations; Drug Interactions; Famotidine; Female; Healthy Volunteers; Humans; Magnesium Hydroxide; Male; Metabolic Clearance Rate; Omeprazole; Simethicone; Young Adult | 2019 |
2 other study(ies) available for aluminum hydroxide, magnesium hydroxide, drug combination and omeprazole
| Article | Year |
|---|---|
Intragastric pH in the gastroprotective and ulcer-healing activity of aluminum-containing antacids.
Topics: Acute Disease; Aluminum Hydroxide; Animals; Antacids; Chronic Disease; Drug Combinations; Ethanol; Female; Gastric Acid; Gastric Mucosa; Hydrogen-Ion Concentration; Indomethacin; Magnesium Hydroxide; Male; Omeprazole; Ranitidine; Rats; Rats, Inbred Strains; Stomach Ulcer | 1991 |
[Decreased plasma levels of omeprazole after coadministration with magnesium-aluminium hydroxide dry suspension granules].
Topics: Administration, Oral; Adult; Aluminum Hydroxide; Antacids; Anti-Ulcer Agents; Drug Combinations; Drug Interactions; Drug Therapy, Combination; Humans; Magnesium Hydroxide; Male; Omeprazole; Tablets, Enteric-Coated | 1999 |